Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): the protocol of an exploratory, randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 09 2020
Historique:
entrez: 8 9 2020
pubmed: 9 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

The US opioid crisis and increasing prescription rates in Europe suggest inappropriate risk perceptions and behaviours of people who prescribe, take or advise on opioids: physicians, patients and pharmacists. Findings from cognitive and decision science in areas other than drug safety suggest that people's risk perception and behaviour can differ depending on whether they learnt about a risk through personal experience or description. ERONA-an exploratory, randomised controlled online survey intervention trial with two parallel arms-will examine the opioid-associated risk perception and behaviour of four groups involved in the long-term administration of WHO-III opioids: (1) family physicians, (2) physicians specialised in pain therapy, (3) patients with chronic (≥3 months) non-cancer pain and (4) pharmacists who regularly dispense narcotic substances. Participants will be randomly assigned to one of two online risk education interventions, description based or experiencebased. Both interventions will present the best medical evidence available. Participants will be queried at baseline and after intervention on their risk perception of opioids' benefit-harm ratio, their medical risk literacy and their current/intended risk behaviour (in terms of prescribing, taking or counselling, depending on study group). A follow-up will occur after 9 months, when participants will be queried on their actual risk behaviour. The study was developed by the authors and will be conducted by the market research institution IPSOS Health. The study was approved by the Institutional Review Board of the Max Planck Institute for Human Development. Results will be disseminated through peer-reviewed journals, conference presentations and social media. DRKS00020358.

Identifiants

pubmed: 32895283
pii: bmjopen-2020-037642
doi: 10.1136/bmjopen-2020-037642
pmc: PMC7476567
doi:

Substances chimiques

Analgesics, Opioid 0

Banques de données

DRKS
['DRKS00020358']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037642

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Cochrane Database Syst Rev. 2017 Jul 06;7:CD012592
pubmed: 28683172
Med Decis Making. 2015 May;35(4):512-24
pubmed: 25378297
Pain. 1986 May;25(2):171-186
pubmed: 2873550
JAMA. 2018 Dec 18;320(23):2448-2460
pubmed: 30561481
Med Decis Making. 2007 Sep-Oct;27(5):655-62
pubmed: 17873258
N Engl J Med. 1980 Jan 10;302(2):123
pubmed: 7350425
Ann Intern Med. 2012 Mar 6;156(5):340-9
pubmed: 22393129
JAMA. 2007 Dec 5;298(21):2517-26
pubmed: 18056905
Pain. 1992 Aug;50(2):133-149
pubmed: 1408309
N Engl J Med. 1978 Nov 2;299(18):999-1001
pubmed: 692627
Ann Intern Med. 1998 Jan 1;128(1):72-3
pubmed: 9424990
J Gen Intern Med. 2003 Nov;18(11):948-59
pubmed: 14687282
Eur J Epidemiol. 2003;18(10):929-31
pubmed: 14598921
BMJ. 2006 Aug 5;333(7562):284
pubmed: 16840441
Mayo Clin Proc. 2013 Aug;88(8):790-8
pubmed: 23871230
Psychol Sci Public Interest. 2007 Nov;8(2):53-96
pubmed: 26161749
BMJ. 2011 Jun 02;342:d3193
pubmed: 21636633
J Gen Intern Med. 1999 Oct;14(10):633-42
pubmed: 10571710
MDM Policy Pract. 2016 Aug 23;1(1):2381468316665365
pubmed: 30288405
Med Decis Making. 2017 Aug;37(6):670-679
pubmed: 28199179
BMJ Qual Saf. 2020 Jun;29(6):521-524
pubmed: 31704891
JAMA Intern Med. 2017 Mar 1;177(3):407-419
pubmed: 28097303
PLoS One. 2018 Sep 13;13(9):e0203800
pubmed: 30212555
Nature. 2019 Sep;573(7773):S10-S12
pubmed: 31511672
Sci Rep. 2018 Nov 21;8(1):17181
pubmed: 30464251
Med Decis Making. 2007 Sep-Oct;27(5):638-54
pubmed: 17873250
Lancet Public Health. 2019 Oct;4(10):e483-e484
pubmed: 31444002
Dtsch Arztebl Int. 2013 Jan;110(4):45-51
pubmed: 23413387
Trends Cogn Sci. 2009 Dec;13(12):517-23
pubmed: 19836292
Med Decis Making. 2011 May-Jun;31(3):386-94
pubmed: 21191123
Acad Med. 1998 May;73(5):538-40
pubmed: 9609869
Lancet Public Health. 2019 Oct;4(10):e498-e505
pubmed: 31444001
Psychol Rev. 2007 Jan;114(1):177-187
pubmed: 17227186
Med Decis Making. 2019 Jan;39(1):41-56
pubmed: 30799691
J Exp Psychol Gen. 2014 Feb;143(1):94-122
pubmed: 23527948
Psychol Bull. 2018 Feb;144(2):140-176
pubmed: 29239630
Ann Intern Med. 2009 Apr 21;150(8):516-27
pubmed: 19221371

Auteurs

Odette Wegwarth (O)

Center for Adaptive Rationality, Max-Planck-Institut für Bildungsforschung, Berlin, Germany wegwarth@mpib-berlin.mpg.de.

Claudia Spies (C)

Department of Anesthesiology and Operative Intensive Care Medicine, Charité, Universitaetsmedizin Berlin, Berlin, Germany.

Erika Schulte (E)

Department of Anesthesiology and Operative Intensive Care Medicine, Charité, Universitaetsmedizin Berlin, Berlin, Germany.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christine Schmucker (C)

Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Edris Nury (E)

Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dirk Brockmann (D)

Institute for Theoretical Biology and Integrative Research, Humboldt University of Berlin, Berlin, Germany.
Epidemiological Modelling of Infectious Diseases, Robert Koch Institut, Berlin, Germany.

Norbert Donner-Banzhoff (N)

Department of Primary Care, University of Marburg, Marburg, Germany.

Stefan Wind (S)

Berlin Chamber of Pharmacists, Berlin, Germany.

Eva Goebel (E)

Berlin Chamber of Pharmacists, Berlin, Germany.

Wolf-Dieter Ludwig (WD)

Drug Commission of the German Medical Association, Berlin, Germany.

Ralph Hertwig (R)

Center for Adaptive Rationality, Max-Planck-Institut für Bildungsforschung, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH